Company Analysis

Lifevantage Corporation (LFVN)

Nasdaq: LFVN · Pharmaceutical Preparations · Lehi, UT · filing with the SEC since 1996
Grade5.8
◀ Past 6.6● Present 6.2▶ Future 4.6

Who runs Lifevantage Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Moorehead Terrence
President and CEO. First filing Aug 2026, latest Oct 9, 2026, 0 filings in all.
Officers reporting now
7
of 13 people with a filing in the last fifteen months
Directors reporting now
6
29 people on the record since 2008
Officerssales are open-market, Nov 9, 2025 to Nov 9, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Moorehead TerrencePresident and CEOAug 2026Oct 9, 2026none
Aure CarlChief Financial OfficerNov 2021Oct 9, 2026none
Cunningham KristenChief Sales OfficerJul 2022Oct 9, 20262 · $100,000
Neufeld AlissaGeneral CounselJun 2021Jul 6, 2026none
Fife Steven RPresident and CEOMar 2017Apr 3, 2026none
Thompson ToddChief Information OfficerOct 2025Dec 29, 2025none
Boyster JulieChief Marketing OfficerFeb 2023Oct 3, 2025none
Directorssales are open-market, Nov 9, 2025 to Nov 9, 2026
NameRoleFirst filingLatest filingSales, 12 months
Anbalagan RajendrandirectorAug 2024Nov 9, 2026none
Beindorff Michael AdirectorJan 2012Nov 9, 20262 · $200,000
Dayton JudddirectorAug 2023Nov 9, 2026none
Greer Raymond BdirectorFeb 2017Nov 9, 2026none
Lewis DarwindirectorFeb 2017Nov 9, 2026none
Latham CynthiadirectorFeb 2022Nov 10, 2025none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton LFVN · research, not advice